More about

Multiple Meyloma

News
April 14, 2022
7 min read
Save

From referral to infusion: Accelerating the CAR-T process

From referral to infusion: Accelerating the CAR-T process

There are many frustrating aspects to a cancer diagnosis.

News
February 28, 2022
1 min read
Save

University of Utah Health appoints radiation oncology department chair

University of Utah Health appoints radiation oncology department chair

Amit Maity, MD, PhD, has been appointed chair of the department of radiation oncology for Spencer Fox Eccles School of Medicine at University of Utah.

News
February 07, 2022
2 min read
Save

Septic shock linked to high mortality rates among patients with hematologic malignancies

Septic shock linked to high mortality rates among patients with hematologic malignancies

Septic shock remained significantly associated with increased 28-day mortality among patients with hematologic malignancies, according to study results published in Journal of the National Comprehensive Cancer Network.

News
December 20, 2021
14 min read
Save

Outpatient therapy: Bringing CAR T cells closer to home

Outpatient therapy: Bringing CAR T cells closer to home

Early clinical trials for the first chimeric antigen receptor T-cell therapies mandated recipients receive rigorous post-treatment monitoring, often requiring inpatient admittance lasting anywhere from 2 to 4 weeks.

News
December 19, 2021
2 min read
Save

12 important studies you may have missed from ASH Annual Meeting and Exposition

12 important studies you may have missed from ASH Annual Meeting and Exposition

Healio provided comprehensive coverage of this year’s ASH Annual Meeting and Exposition.

News
December 15, 2021
3 min read
Save

Daratumumab regimen extends PFS among certain patients with relapsed or refractory myeloma

Daratumumab regimen extends PFS among certain patients with relapsed or refractory myeloma

The addition of daratumumab to pomalidomide and dexamethasone extended PFS among patients with relapsed or refractory multiple myeloma who were refractory to lenalidomide, according to a study presented at ASH Annual Meeting and Exposition.

News
October 28, 2021
4 min read
Save

Earlier CAR-T treatment possible if price comes down, FDA official says

Earlier CAR-T treatment possible if price comes down, FDA official says

Expanded use of chimeric antigen receptor T cells for cancer treatment requires that less expensive therapies be developed faster using multiple manufacturing models, according to an FDA official.

News
October 18, 2021
2 min read
Save

CDC chief urged to extend COVID-19 vaccine boosters to caregivers of patients with cancer

CDC chief urged to extend COVID-19 vaccine boosters to caregivers of patients with cancer

American Association for Cancer Research urged the CDC to expand availability of COVID-19 booster vaccinations to caregivers and other individuals who share a home with patients with cancer.

View more